Buy Atea Pharmaceuticals Stock | AVIR Stock Price & Latest News | Public
AVIR

Atea Pharmaceuticals

$0.00 (0.00%)Today

    About AVIR

    Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Stats

    Market Cap$2,79B
    Volume11,45k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$36.65
    1 Year Low$24.15
    Open$34.49
    High$34.82
    Low$33.66

    Buy any stock with any amount of money.

    Download the App
    Download the app